Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy

The synthesis of ruthenium(II) and osmium(II) arene complexes with the closely related indolo3,2-c]quinolines N-(11H-indolo3,2-c]quinolin-6-yl)-ethane-1,2-diamine (L ¹ ) and N′-(11H-indolo3,2-c]quinolin-6-yl)-N,N-dimethylethane-1,2-diamine (L ² ) and indolo3,2-d]benzazepines N-(7,12-dihydroindolo-3,2-d]1]benzazepin-6-yl)-ethane-1,2-diamine (L ³ ) and N′-(7,12-dihydroindolo-3,2-d]1]benzazepin-6-yl)-N,N-dimethylethane-1,2-diamine (L ⁴ ) of the general formulas (η⁶-p-cymene)M^II(L ¹ )Cl]Cl, where M is Ru (4) and Os (6), (η⁶-p-cymene)M^II(L ² )Cl]Cl, where M is Ru (5) and Os (7), (η⁶-p-cymene)M^II(L ³ )Cl]Cl, where M is Ru (8) and Os (10), and (η⁶-p-cymene)M^II(L ⁴ )Cl]Cl, where M is Ru (9) and Os (11), is reported. The compounds have been comprehensively characterized by elemental analysis, electrospray ionization mass spectrometry, spectroscopy (IR, UV–vis, and NMR), and X-ray crystallography (L ¹ ·HCl, 4·H₂O, 5, and 9·2.5H₂O). Structure–activity relationships with regard to cytotoxicity and cell cycle effects in human cancer cells as well as cyclin-dependent kinase (cdk) inhibition and DNA intercalation in cell-free settings have been established. The metal-free indolo3,2-c]quinolines inhibit cancer cell growth in vitro, with IC₅₀ values in the high nanomolar range, whereas those of the related indolo3,2-d]benzazepines are in the low micromolar range. In cell-free experiments, these classes of compounds inhibit the activity of cdk2/cyclin E, but the much higher cytotoxicity and stronger cell cycle effects of indoloquinolines L ¹ and 7 are not paralleled by a substantially higher kinase inhibition compared with indolobenzazepines L ⁴ and 11, arguing for additional targets and molecular effects, such as intercalation into DNA.